Enhanced Cardiac Regenerative Ability of Stem Cells After Ischemia-Reperfusion Injury: Role of Human CD34+ Cells Deficient in MicroRNA-377.

[1]  T. Jiang,et al.  MicroRNA-377 inhibited proliferation and invasion of human glioblastoma cells by directly targeting specificity protein 1. , 2014, Neuro-oncology.

[2]  Xiaohong Wang,et al.  MicroRNA-377 Regulates Mesenchymal Stem Cell-Induced Angiogenesis in Ischemic Hearts by Targeting VEGF , 2014, PloS one.

[3]  R. Thandavarayan,et al.  Small Engine, Big Power: MicroRNAs as Regulators of Cardiac Diseases and Regeneration , 2014, International journal of molecular sciences.

[4]  M. Latronico,et al.  Circulating miR-29a, among other up-regulated microRNAs, is the only biomarker for both hypertrophy and fibrosis in patients with hypertrophic cardiomyopathy. , 2014, Journal of the American College of Cardiology.

[5]  T. Thum,et al.  Non-coding RNAs in cardiac remodeling and heart failure. , 2013, Circulation research.

[6]  Danish Sayed,et al.  GATA4 expression is primarily regulated via a miR-26b-dependent post-transcriptional mechanism during cardiac hypertrophy. , 2012, Cardiovascular research.

[7]  Francisco Caiado,et al.  Endothelial progenitor cells and integrins: adhesive needs , 2012, Fibrogenesis & tissue repair.

[8]  E. Olson,et al.  Inhibition of miR-15 Protects Against Cardiac Ischemic Injury , 2012, Circulation research.

[9]  R. Kishore,et al.  Interleukin-10 Deficiency Impairs Bone Marrow–Derived Endothelial Progenitor Cell Survival and Function in Ischemic Myocardium , 2011, Circulation research.

[10]  W. Sessa.  MicroRNA regulation of cardiovascular functions. , 2011, Arteriosclerosis, Thrombosis and Vascular Biology.

[11]  G. Dorn,et al.  miR-15 Family Regulates Postnatal Mitotic Arrest of Cardiomyocytes , 2011, Circulation research.

[12]  T. Henry,et al.  Intramyocardial, Autologous CD34+ Cell Therapy for Refractory Angina , 2011, Circulation research.

[13]  G. Dorn.  MicroRNAs in cardiac disease. , 2011, Translational research : the journal of laboratory and clinical medicine.

[14]  L. V. Van Laake,et al.  miR-24 inhibits apoptosis and represses Bim in mouse cardiomyocytes , 2011, The Journal of experimental medicine.

[15]  M. Abdellatif,et al.  Thioredoxin 1 Negatively Regulates Angiotensin II–Induced Cardiac Hypertrophy Through Upregulation of miR-98/let-7 , 2011, Circulation research.

[16]  Abhishek Kumar,et al.  STK35L1 Associates with Nuclear Actin and Regulates Cell Cycle and Migration of Endothelial Cells , 2011, PloS one.

[17]  V. Thayanithy,et al.  Regulation of Heme Oxygenase-1 Protein Expression by miR-377 in Combination with miR-217* , 2010, The Journal of Biological Chemistry.

[18]  R. Kishore,et al.  Myocardial knockdown of mRNA‐stabilizing protein HuR attenuates post‐MI inflammatory response and left ventricular dysfunction in IL‐10‐null mice , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[19]  Yan Zeng,et al.  Alteration of microRNA expression in vinyl carbamate-induced mouse lung tumors and modulation by the chemopreventive agent indole-3-carbinol. , 2010, Carcinogenesis.

[20]  D. Glavač,et al.  MicroRNAs miR-1, miR-133a, miR-133b and miR-208 Are Dysregulated in Human Myocardial Infarction , 2009, Cardiology.

[21]  Mark D. Huffman,et al.  Heart Disease and Stroke Statistics—2015 Update: A Report From the American Heart Association , 2009, Circulation.

[22]  O. Maes,et al.  Stepwise up‐regulation of MicroRNA expression levels from replicating to reversible and irreversible growth arrest states in WI‐38 human fibroblasts , 2009, Journal of cellular physiology.

[23]  Christophe Lemetre,et al.  MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2/neu receptor status in breast cancer , 2009, Breast Cancer Research.

[24]  Y. Suárez,et al.  MicroRNAs as novel regulators of angiogenesis. , 2009, Circulation research.

[25]  Raj Kishore,et al.  IL-10 Inhibits Inflammation and Attenuates Left Ventricular Remodeling After Myocardial Infarction via Activation of STAT3 and Suppression of HuR , 2009, Circulation research.

[26]  R. Quigg,et al.  MicroRNA‐377 is up‐regulated and can lead to increased fibronectin production in diabetic nephropathy , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[27]  Jeffrey E. Thatcher,et al.  Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis , 2008, Proceedings of the National Academy of Sciences.

[28]  A. Tucker,et al.  Regulation of cardiac myocyte contractility by phospholemman: Na+/Ca2+ exchange versus Na+ -K+ -ATPase. , 2008, American journal of physiology. Heart and circulatory physiology.

[29]  Artemis G. Hatzigeorgiou,et al.  Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer , 2008, Proceedings of the National Academy of Sciences.

[30]  K. Chatila,et al.  CD44 Is Critically Involved in Infarct Healing by Regulating the Inflammatory and Fibrotic Response1 , 2008, The Journal of Immunology.

[31]  G. Marenzi,et al.  Improved clinical outcome after intracoronary administration of bone marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial. , 2007, European heart journal.

[32]  Yong Zhao,et al.  A developmental view of microRNA function. , 2007, Trends in biochemical sciences.

[33]  K. Osterziel.  Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1 year results of the REPAIR-AMI trial. , 2006, European heart journal.

[34]  E. Olson,et al.  A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure , 2006, Proceedings of the National Academy of Sciences.

[35]  Renzo Boldorini,et al.  Frequent alterations in the expression of serine/threonine kinases in human cancers. , 2006, Cancer research.

[36]  I. Grummt.  Actin and myosin as transcription factors. , 2006, Current opinion in genetics & development.

[37]  M. Burnett,et al.  Local Delivery of Marrow-Derived Stromal Cells Augments Collateral Perfusion Through Paracrine Mechanisms , 2004, Circulation.

[38]  S. Silver,et al.  Heart Failure , 1937, The New England journal of medicine.

[39]  Douglas Losordo,et al.  CD34-positive stem cells: in the treatment of heart and vascular disease in human beings. , 2011, Texas Heart Institute journal.

[40]  Regina Berretta,et al.  Genetic signatures for a rodent model of Parkinson's disease using combinatorial optimization methods. , 2008, Methods in molecular biology.